Defining Accurate & Meaningful Clinical Trial Designs to Allow Earlier Identification of Drug Efficacy
Time: 10:30 am
day: Day Two
Details:
- De-risking phase II and III clinical trials to allow better outcomes with more accurate results
- Describing risk factors and disease endotypes in evaluation for HFpEF clinical trials
